publication date: May. 2, 2016

Prostate Cancer Study: SBRT Delivers 98.6% Cure Rate at Five-Year Followup


A five-year study showed that stereotactic body radiation therapy to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.

The study, the first trial to publish five-year results from SBRT treatment for prostate cancer, according to the researchers, found a 98.6 percent cure rate with SBRT.

“The high cure rate is striking when compared to the reported five-year cure rates from other approaches like surgery or conventional radiation, which range between 80 to 90 percent, while the side effects of this treatment are comparable to other types of treatment,” said Raquibul Hannan, assistant professor of radiation oncology and lead author for the study.

UT Southwestern served as the lead site for the multi-institutional clinical trial, which involved first-time prostate cancer patients diagnosed with stage I or II prostate cancer. A total of 91 patients were treated prospectively and followed for five years, with only one patient experiencing a recurrence of his cancer. The findings were published in the European … Continue reading CCL April – Study: SBRT Delivers 98.6% Cure Rate at Five-Year Followup

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.